Table 3.

Adverse events in patients treated with G3139 and FLAG

No. of patients with event of common toxicity criteria
EventGrade 1Grade 2Grade 3Grade 4
Gastrointestinal     
 Emesis 10 
 Diarrhea 14 0  
 Mucositis 
Liver functions     
 Total bilirubin 1  
 Transaminases 
 Alkaline phosphatase 
Cardiovascular     
 Chest pain 
 Dizziness 
 Hypertension 
 Hypotension 
Respiratory     
 Hypoxia 12 
 Dyspnea 10 
Renal     
 Increased creatinine level 0  
 Fluid retention 11 
Electrolytes     
 Hyponatremia 
 Hypokalemia 
 Hypocalcemia 10 
 Hypercalcemia 
 Hypophosphatemia 
 Hyperphosphatemia 
 Hypomagnesemia 15 
Neurologic     
 Headache 
 Seizure 
Coagulation     
 Increased PTT 0  
 Increased PT 
Skin rash 0  
Tumor lysis 
No. of patients with event of common toxicity criteria
EventGrade 1Grade 2Grade 3Grade 4
Gastrointestinal     
 Emesis 10 
 Diarrhea 14 0  
 Mucositis 
Liver functions     
 Total bilirubin 1  
 Transaminases 
 Alkaline phosphatase 
Cardiovascular     
 Chest pain 
 Dizziness 
 Hypertension 
 Hypotension 
Respiratory     
 Hypoxia 12 
 Dyspnea 10 
Renal     
 Increased creatinine level 0  
 Fluid retention 11 
Electrolytes     
 Hyponatremia 
 Hypokalemia 
 Hypocalcemia 10 
 Hypercalcemia 
 Hypophosphatemia 
 Hyperphosphatemia 
 Hypomagnesemia 15 
Neurologic     
 Headache 
 Seizure 
Coagulation     
 Increased PTT 0  
 Increased PT 
Skin rash 0  
Tumor lysis 

PTT indicates partial thromboplastin time; and PT, prothrombin time.

Close Modal

or Create an Account

Close Modal
Close Modal